2 active not recruiting. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Active not recruiting 2 |
Follow SC291: new trials by email Literature Review of SC291 trials Research Report on SC291
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) SC291 - Lupus Erythematosus, Systemic Lupus Erythematosus | Phase 1 | Active not recruiting | Sana Biotechnology | 7 | 2024-04-29 | 2025-11-25 |
| Study Evaluating SC291 in Subjects With r/r B-cell Malignancies (ARDENT) SC291 - Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia | Phase 1 | Active not recruiting | Sana Biotechnology | 16 | 2023-05-02 | 2025-10-02 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Autoimmune Diseases (1) · Granulomatosis with Polyangiitis (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lupus Erythematosus, Systemic (1) · Lupus Nephritis (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Microscopic Polyangiitis (1) · Vasculitis (1)
United States (2) · Australia (1)
John Gerecitano, MD, PhD (1) · Kristen Lee (1)